A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation

Clinical trial NCT07752875 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07752875
Sponsor: LG Chem
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Small Cell Lung Cancer Non Small Cell Lung Cancer Colorectal Cancer Esophageal Cancer Breast Cancer Endometrial Cancer Head and Neck Cancer Pancreatic Cancer Locally Advanced Unresectable or Metastatic Solid Tumor

Start date: 2026-12-01
Primary completion: 2032-10-31
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.